Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Gossamer Bio
company
About
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
- 101 - 250
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $100M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$330M
Gossamer Bio has raised a total of
$330M
in funding over 2 rounds. Their latest funding was raised on
Jul 23, 2018 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 23, 2018 | Series B | $230M | 2 | — | — | Detail |
| Jan 4, 2018 | Series A | $100M | 1 |
ARCH Venture Partners
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Gossamer Bio is funded by 2 investors.
ARCH Venture Partners
and Abu Dhabi Investment Authority
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
ARCH Venture Partners
|
— | Series B |
Abu Dhabi Investment Authority
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
